Pharmaceutical Industry Today

Global Biopharmaceuticals Market: Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Biopharmaceuticals Market report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency.
Published 20 June 2018

This report studies the Biopharmaceuticals market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Request Sample Copy of the Report @

It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associated

With manufacturing (if the trials are successful).

An additional point is that European R&D costs are higher than in other world regions due to the fragmented European patent system. The implications of a fragmented patent system in Europe include high uncertainty, quality drop and prohibitive costs, which are at least four times higher than in the US, China and South Korea thus constituting a financial burden on especially small biopharmaceutical enterprises in Europe (van Pottelsberghe 2009).

The global Biopharmaceuticals market was xx million US$ in 2017 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2018 and 2025.

Ask for Discount on Research Report@

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Biopharmaceuticals in these regions, from 2013 to 2025, covering

  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
  •     Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
  •     South America (Brazil etc.)
  •     Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

  •     Roche
  •     Amgen
  •     AbbVie
  •     Sanofi-Aventis
  •     Johnson & Johnson
  •     Pfizer
  •     Novo Nordisk
  •     Eli Lilly
  •     Novartis
  •     Merck

By the product type, the market is primarily split into

  •     Monoclonal Antibodies
  •     Interferon
  •     Colony-Stimulating Factor
  •     Erythropoietin
  •     Insulin
  •     Vaccines
  •     Growth Hormones
  •     Others

By the end users/application, this report covers the following segments

  •     Tumor
  •     Diabetes
  •     Cardiovascular
  •     Hemophilia
  •     Others
Click to request a sample:

Other Industry News

Ready to start publishing

Sign Up today!